For low- and middle-income countries, a COVID-19 vaccination program built on prompt procurement, effective on-the-ground distribution, and a rapid pace of vaccination (the total number of doses given daily) is likely to ...
Oct 29, 2021
1
53
An expert review by an international group of scientists, including some at the WHO and FDA, concludes that, even for the delta variant, vaccine efficacy against severe COVID is so high that booster doses for the general ...
Sep 13, 2021
0
516
As new COVID-19 variants begin to throw vaccine efficacy in question, two leading scientists are calling for health agencies to invest in the development of vaccines that would be broadly effective against many different ...
Feb 9, 2021
5
54
Researchers at the University of Oxford have today published in Preprints with The Lancet an analysis of further data from the ongoing trials of the vaccine. In this, they reveal that the vaccine efficacy is higher at longer ...
Feb 3, 2021
0
92
The government vaccination program may not be sufficient to achieve herd immunity—even if everyone in the UK is vaccinated—according to new research from the University of East Anglia.
Jan 21, 2021
2
1028
Elderly people are more prone to infectious diseases as the function of their immune system continuously declines with progression of age. This becomes especially apparent during seasonal influenza outbreaks or the occurrence ...
Jul 6, 2020
0
639
Vaccines are one of the most effective interventions to prevent the spreading of infectious diseases. They trigger the immune system to produce antibodies that protect the body against infection. However, we still lack efficacious ...
May 14, 2020
2
344
Molecular signatures before and after immunization can predict vaccine-induced protection, according to a study by ISGlobal. The study analysed the gene expression in peripheral blood cells from individuals immunized with ...
May 13, 2020
0
59
Giving children an additional dose of rotavirus vaccine when they are nine months old would provide only a modest improvement in the vaccine's effectiveness in low-income countries concerned about waning protection against ...
Aug 14, 2019
0
62
Preclinical experiments by University of Alabama at Birmingham researchers suggest the cancer drugs vorinostat, belinostat and panobinostat might be repurposed to treat infections caused by human papillomaviruses, or HPVs.
Dec 1, 2018
0
126
